Follow Us
© 2026 Arizent. All rights reserved.
In the first half of the year, the MIB Life Index is up 2.8% year-to-date (YTD) compared to the same six months last year.
The index has posted positive numbers in eight of the past nine months. However, quarterly numbers show easing growth – up 1.3% Q2 2012/2011 and up 4.2% Q1 2012/2011. June’s numbers were up 2.2% from those of May and 2.1% from those of June 2011.
For reprint and licensing requests for this article, click here.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
Engaging communication strategies will be key to getting employees interested in evaluating benefit options and making more informed decisions.
Metabolism-management drugs and hormone therapy are growing in popularity, but women need expert clinical oversight in conjunction with medication access.
To truly flip the script on metabolic disease, benefit leaders must build a cost-efficient, supportive plan for employees and their business.
Brokers have both an opportunity and responsibility to educate their clients toward better health outcomes and less financial volatility, not just a yes/no on coverage.
